Literature DB >> 1840701

Structure and functional expression of a human interleukin-8 receptor.

W E Holmes1, J Lee, W J Kuang, G C Rice, W I Wood.   

Abstract

Interleukin-8 (IL-8) is a member of a family of pro-inflammatory cytokines. Although the best characterized activities of IL-8 include the chemoattraction and activation of neutrophils, other members of this family have a wide range of specific actions including the chemotaxis and activation of monocytes, the selective chemotaxis of memory T cells, the inhibition of hematopoietic stem cell proliferation, and the induction of neutrophil infiltration in vivo. A complementary DNA encoding the IL-8 receptor from human neutrophils has now been isolated. The amino acid sequence shows that the receptor is a member of the superfamily of receptors that couple to guanine nucleotide binding proteins (G proteins). The sequence is 29% identical to that of receptors for the other neutrophil chemoattractants, fMet-Leu-Phe and C5a. Mammalian cells transfected with the IL-8 receptor cDNA clone bind IL-8 with high affinity and respond specifically to IL-8 by transiently mobilizing calcium. The IL-8 receptor may be part of a subfamily of related G protein-coupled receptors that transduce signals for the IL-8 family of pro-inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1840701     DOI: 10.1126/science.1840701

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  225 in total

Review 1.  Chemokines. Introduction.

Authors:  K Matsushima
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 3.  Antituberculosis treatment: increasing evidence for drug effects on innate cellular immunity.

Authors:  C T Tiemessen; S Shalekoff; S Meddows-Taylor; D J Martin
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

4.  Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials.

Authors:  S J Prest; R C Rees; C Murdoch; J F Marshall; P A Cooper; M Bibby; G Li; S A Ali
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

5.  A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.

Authors:  Kozi Ichiyama; Sei Yokoyama-Kumakura; Yuetsu Tanaka; Reiko Tanaka; Kunitaka Hirose; Kenji Bannai; Takeo Edamatsu; Mikiro Yanaka; Yoshiaki Niitani; Naoko Miyano-Kurosaki; Hiroshi Takaku; Yoshio Koyanagi; Naoki Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

6.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

7.  New take on comparative immunology: relevance to immunotherapy.

Authors:  Ena Wang; Adriana Albini; David F Stroncek; Francesco M Marincola
Journal:  Immunotherapy       Date:  2009-05       Impact factor: 4.196

8.  Il-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation.

Authors:  Eugene V Vykhovanets; Sanjeev Shukla; Gregory T MacLennan; Olena V Vykhovanets; Donald R Bodner; Sanjay Gupta
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

9.  Hypoxia promotes the proliferation of cervical carcinoma cells through stimulating the secretion of IL-8.

Authors:  Li-Bing Liu; Feng Xie; Kai-Kai Chang; Ming-Qing Li; Yu-Han Meng; Xiao-Hui Wang; Hui Li; Da-Jin Li; Jin-Jin Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 10.  Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.

Authors:  Lu Miao; Aaron K Holley; Yanming Zhao; William H St Clair; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2014-01-22       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.